Trial · NCT01000961
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Run-in Period of 2-3 Weeks on Cystagon | STARTED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| Run-in Period of 2-3 Weeks on Cystagon | STARTED | Cystagon First, Then RP103, Then Cystagon | 22 | |
| Run-in Period of 2-3 Weeks on Cystagon | COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| Run-in Period of 2-3 Weeks on Cystagon | COMPLETED | Cystagon First, Then RP103, Then Cystagon | 22 | |
| Run-in Period of 2-3 Weeks on Cystagon | NOT COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 0 | |
| Run-in Period of 2-3 Weeks on Cystagon | NOT COMPLETED | Cystagon First, Then RP103, Then Cystagon | 0 | |
| First Intervention (3 Weeks) | STARTED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| First Intervention (3 Weeks) | STARTED | Cystagon First, Then RP103, Then Cystagon | 22 | |
| First Intervention (3 Weeks) | COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| First Intervention (3 Weeks) | COMPLETED | Cystagon First, Then RP103, Then Cystagon | 20 | |
| First Intervention (3 Weeks) | NOT COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 0 | |
| First Intervention (3 Weeks) | NOT COMPLETED | Cystagon First, Then RP103, Then Cystagon | 2 | |
| Second Intervention (3 Weeks) | STARTED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| Second Intervention (3 Weeks) | STARTED | Cystagon First, Then RP103, Then Cystagon | 20 | |
| Second Intervention (3 Weeks) | COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 21 | |
| Second Intervention (3 Weeks) | COMPLETED | Cystagon First, Then RP103, Then Cystagon | 20 | |
| Second Intervention (3 Weeks) | NOT COMPLETED | Cystagon First, Then Cystagon, Then RP103 | 0 | |
| Second Intervention (3 Weeks) | NOT COMPLETED | Cystagon First, Then RP103, Then Cystagon | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01000961/flow